Application of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1α expression in patients with glioma.
about
Imaging Modalities to Assess Oxygen Status in GlioblastomaImaging tumour hypoxia with positron emission tomographyPositron emission tomography to assess hypoxia and perfusion in lung cancerMolecular mechanisms of hypoxia in cancer.PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence(68)Ga-PRGD2 PET/CT in the evaluation of Glioma: a prospective study.Evaluation of hypoxia with copper-labeled diacetyl-bis(N-methylthiosemicarbazone).Assessment of the Tumor Redox Status in Head and Neck Cancer by 62Cu-ATSM PET.Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.Usefulness of FMISO-PET for glioma analysis.Molecular imaging of hypoxia in non-small-cell lung cancer.64Cu-ATSM internal radiotherapy to treat tumors with bevacizumab-induced vascular decrease and hypoxia in human colon carcinoma xenografts.Multiple Administrations of 64Cu-ATSM as a Novel Therapeutic Option for Glioblastoma: a Translational Study Using Mice with Xenografts.GBM radiosensitizers: dead in the water…or just the beginning?Standardized uptake value in high uptake area on positron emission tomography with 18F-FRP170 as a hypoxic cell tracer correlates with intratumoral oxygen pressure in glioblastoma.Imaging the Tumor Microenvironment.Tumor hypoxia and microscopic diffusion capacity in brain tumors: a comparison of (62)Cu-Diacetyl-Bis (N4-Methylthiosemicarbazone) PET/CT and diffusion-weighted MR imaging.(62)Cu-diacetyl-bis (N(4)-methylthiosemicarbazone) PET in human gliomas: comparative study with [(18)F]fluorodeoxyglucose and L-methyl-[(11)C]methionine PET.Uniform intratumoral distribution of radioactivity produced using two different radioagents, 64Cu-cyclam-RAFT-c(-RGDfK-)4 and 64Cu-ATSM, improves therapeutic efficacy in a small animal tumor model.
P2860
Q26782708-7F25C620-470E-4BB4-BCCD-532B55782DC0Q26851422-0D35317F-1982-4AA0-9A5B-95A12A1F7AF4Q27026940-445BB3B8-FED9-48F0-8638-26F52D76B45AQ33705108-F1217882-E4C1-447C-98C3-52B5F520A88FQ33818999-97532F6A-0050-413C-8341-33FB9F5FAE41Q34473605-DA265AE3-82C4-4C00-8AD4-8949780A15B6Q35116540-3AFE1DBB-1149-4D2F-88BD-263E92DCAD13Q36020018-2F2CBCA6-2DC6-4707-9656-90503E0BBD3CQ37236103-FE4E3375-7E43-459E-A345-07F45F1754E8Q38156537-274EF975-23BD-4FB7-ACED-E7E6B5BDB1E2Q38363234-31EE7994-62F3-457F-9792-72AC73404F8EQ47115808-E4D4D965-3E8C-4280-ACE4-78EB23E8779FQ47124032-2975A28F-D07A-4A44-8268-5430E9F7D1B2Q47949771-DBC20394-53B3-4E24-8BEE-E9910774F98DQ47966116-369FECD8-2798-4937-AEEA-E6CA7932C97BQ49592815-32B03E88-5A7B-4C14-8776-F53A79DF0F77Q53070645-539C10C4-1FAE-4EB2-A0C3-5688460F5A6AQ53098904-B595A031-8EA1-40CA-B4E2-FF9DD85F7196Q55442958-98671223-A20C-49BD-BA39-D8DFAF0617FF
P2860
Application of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1α expression in patients with glioma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Application of 62Cu-diacetyl-b ...... ssion in patients with glioma.
@en
Application of 62Cu-diacetyl-bis
@nl
type
label
Application of 62Cu-diacetyl-b ...... ssion in patients with glioma.
@en
Application of 62Cu-diacetyl-bis
@nl
prefLabel
Application of 62Cu-diacetyl-b ...... ssion in patients with glioma.
@en
Application of 62Cu-diacetyl-bis
@nl
P2093
P2860
P356
P1476
Application of 62Cu-diacetyl-b ...... ssion in patients with glioma.
@en
P2093
K Tateishi
N Kawahara
S Yamanaka
U Tateishi
P2860
P356
10.3174/AJNR.A3159
P577
2012-06-14T00:00:00Z